FingerprintDive into the research topics of 'Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator'. Together they form a unique fingerprint.
- Sort by
Adrian Vella, Jennifer L.R. Freeman, Imogene Dunn, Kit Keller, John B. Buse, Carmen Valcarce
Research output: Contribution to journal › Article › peer-review